Form 4: Lemaitre Vascular Exec Reports Stock Transactions

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported recent stock acquisitions from vested dividend equivalent rights and dispositions for tax withholding.

Summary

• Trent G. Kamke, Senior V.P., Operations at Lemaitre Vascular Inc. (LMAT), reported multiple transactions involving common stock.
• Acquired a total of 27 shares of common stock at a price of $0 per share through the release of dividend equivalent rights (DERs) on December 11 and 12, 2025.
• Disposed of a total of 270 shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs) and performance stock units (PSUs).
• The disposition prices were $83.36 for 90 shares on December 11, 2025, and $84 for 180 shares on December 12, 2025.
• The transactions relate to RSU awards granted on December 11, 2021, and RSU/PSU awards granted on December 12, 2022.
• Beneficial ownership of common stock decreased from 4,671 shares (after the first reported acquisition) to 4,417 shares following all reported transactions.

Sentiment

Score: 5

Explanation: The filing reports routine, pre-scheduled insider transactions related to executive compensation, which are neutral in terms of company performance or strategic outlook.

Positives

• Acquisition of 27 shares of common stock at $0 cost through the exercise of dividend equivalent rights, indicating the vesting of previously granted equity compensation.

Negatives

• Disposition of 270 shares to cover tax withholding obligations, resulting in a net decrease of 243 shares from the total acquired (27) versus total disposed (270) in these transactions.
• The overall beneficial ownership of common stock decreased by 254 shares from the initial reported balance of 4,671 to 4,417 shares.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transactions represent a routine aspect of executive compensation and are unlikely to have a significant direct impact on shareholder value or the company's operational performance.
• Employees: Reflects standard executive compensation practices, which may be consistent with broader company compensation policies.

Key Dates

Recommendation

The Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of restricted stock units and performance stock units, and the subsequent sale of shares to cover tax obligations. These transactions are pre-scheduled and do not indicate any change in the company's operational performance or strategic direction. Therefore, the filing itself does not provide a basis for a change in investment recommendation.

Keywords

LEMAITRE VASCULAR, LMAT, Form 4, insider trading, stock transactions, executive compensation, restricted stock units, performance stock units, dividend equivalent rights